Is Poly Medicure a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Poly Medicure Ltd is a good quality company .

Is Poly Medicure undervalued or overvalued?

The key valuation ratios of Poly Medicure Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Poly Medicure share price return in the past 10 years?

Poly Medicure Ltd share price has appreciated 30.1% annually (CAGR) over the past ten years.

Is Poly Medicure a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Poly Medicure Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

Poly Medicure Ltd - Stock Valuation and Financial Performance

Name: Poly Medicure
Brand: Poly Medicure

BSE: 531768 | NSE: POLYMED | Medical Equipment/Supplies/Accessories | Small Cap

Place order

Poly Medicure Share Price

₹2,864 -298.70 -9.44%
as on 04-Nov'24 15:31

10 Year X-Ray of Poly Medicure:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	39.4%	26.1%	25.3%	26%	22.9%	24.6%	21.6%	17.7%	19.3%	23.3%	-
Value Creation Index ⓘ	1.8	0.9	0.8	0.9	0.6	0.8	0.6	0.3	0.4	0.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	374	394	440	508	587	646	747	879	1,068	1,307	1,452
Sales YoY Gr.	-	5.6%	11.4%	15.7%	15.4%	10.1%	15.7%	17.7%	21.5%	22.4%	-
Adj EPS ⓘ	5	5	5.6	7.1	6.9	9.6	12.9	14.3	17.9	25	28.8
YoY Gr.	-	0.8%	12.4%	27.1%	-3.1%	39.4%	34%	10.7%	25.6%	39.6%	-
BVPS (₹) ⓘ	21.8	25.4	30.5	37.9	43	48.6	99.4	112.1	128.4	151.6	254.1
Adj Net Profit ⓘ	43.7	44	49.5	62.9	60.9	85	124	137	172	240	291
Cash Flow from Ops. ⓘ	63.3	61.9	55	75.5	113	127	116	126	197	256	-
Debt/CF from Ops. ⓘ	1.2	1.3	1.8	1.7	1.3	1.5	1.1	0.9	0.7	0.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	14.9%	17.4%	20.5%	22.4%
Adj EPS ⓘ	19.7%	29.4%	24.7%	39.6%
BVPSⓘ	24.1%	28.7%	15.1%	18.1%
Share Price	30.1%	69.6%	46.5%	95.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	26	21.2	20.1	20.8	17.1	21	17.9	13.5	14.9	17.8	14.2
Op. Profit Mgn % ⓘ	22.6	21.9	21.4	23.9	22.8	25.1	28.2	24.3	25.3	26.9	27.3
Net Profit Mgn % ⓘ	11.7	11.2	11.3	12.4	10.4	13.2	16.5	15.6	16.1	18.4	20.1
Debt to Equity ⓘ	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.1	0.1	0.1	0
Working Cap Days ⓘ	136	144	146	157	159	173	182	177	173	167	154
Cash Conv. Cycle ⓘ	54	67	75	80	80	78	78	89	92	87	112

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 20.49%

Net Profit is growing at healthy rate in last 3 years 24.73%

Sales growth is good in last 4 quarters at 21.80%

Return on Equity has declined versus last 3 years average to 14.20%

Latest Financials - Poly Medicure Ltd.

	Standalone	Consolidated
TTM EPS (₹)	28.8	29.1
TTM Sales (₹ Cr.)	1,452	1,522
BVPS (₹.) ⓘ	254.1	255.7
Reserves (₹ Cr.) ⓘ	2,524	2,541
P/BV ⓘ	12.44	12.36
PE ⓘ	109.84	108.59

From the Market
52 Week Low / High (₹)	1360.95 / 3350.00
All Time Low / High (₹)	0.50 / 2977.55
Market Cap (₹ Cr.)	32,019
Equity (₹ Cr.)	50.7
Face Value (₹)	5
Industry PE ⓘ	95.3

Management X-Ray of Poly Medicure:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Poly Medicure

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Poly Medicure

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	374	394	439	508	587	646	747	879	1,068	1,307
Operating Expenses ⓘ	289	308	345	387	453	484	537	665	802	956
Manufacturing Costs	96	100	113	131	143	153	162	200	243	275
Material Costs	103	107	110	121	152	153	197	261	300	364
Employee Cost	60	69	81	94	110	127	131	150	188	229
Other Costs ⓘ	30	33	41	41	48	51	47	54	70	88
Operating Profit ⓘ	85	86	94	122	134	162	210	214	266	352
Operating Profit Margin (%)	22.6%	21.9%	21.4%	23.9%	22.8%	25.1%	28.1%	24.3%	24.9%	26.9%
Other Income ⓘ	8	8	14	14	16	19	19	39	36	58
Interest ⓘ	10	10	8	11	13	20	10	5	10	13
Depreciation ⓘ	18	20	23	28	36	39	46	53	56	62
Exceptional Items ⓘ	20	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	84	65	76	96	100	122	173	195	237	335
Tax ⓘ	23	18	20	26	34	29	44	49	58	83
Profit After Tax	61	47	56	70	66	92	130	146	179	252
PAT Margin (%)	16.3%	12.0%	12.8%	13.8%	11.3%	14.3%	17.3%	16.6%	16.8%	19.3%
Adjusted EPS (₹)	6.9	5.4	6.4	8.0	7.5	10.5	13.5	15.2	18.7	26.2
Dividend Payout Ratio (%)	18%	28%	39%	25%	27%	19%	19%	16%	16%	11%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	192	224	269	334	379	429	953	1,075	1,232	1,455
Share Capital ⓘ	22	22	44	44	44	44	48	48	48	48
Reserves ⓘ	170	202	225	290	335	385	905	1,027	1,184	1,407
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	58	61	76	106	127	155	91	81	112	146
Long Term Debt	40	31	48	79	91	111	60	31	12	1
Short Term Debt	18	30	28	27	35	44	31	50	101	145
Trade Payables	38	30	41	43	50	60	56	78	78	89
Others Liabilities ⓘ	66	61	63	71	105	128	131	100	173	204
Total Liabilities ⓘ	354	376	449	555	661	772	1,231	1,334	1,596	1,894
Fixed Assets
Gross Block	252	288	333	417	461	550	655	764	963	1,255
Accumulated Depreciation	91	111	133	161	192	226	270	317	365	424
Net Fixed Assetsⓘ	161	177	200	256	269	324	385	447	597	831
CWIP ⓘ	10	14	20	18	19	25	21	43	78	71
Investmentsⓘ	6	6	6	18	46	58	385	384	181	221
Inventories	54	41	58	69	74	101	109	150	183	193
Trade Receivables	59	81	95	112	124	120	149	191	221	259
Cash Equivalents	20	21	22	20	53	22	27	8	171	137
Others Assetsⓘ	45	37	47	61	76	122	154	110	165	183
Total Assets ⓘ	354	376	449	555	661	772	1,231	1,334	1,596	1,894

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	63	62	55	75	113	127	116	126	197	256
PBT ⓘ	65	65	76	96	100	122	173	195	237	335
Adjustment ⓘ	41	25	22	38	41	50	45	39	60	36
Changes in Working Capital ⓘ	-19	-14	-25	-36	-1	-10	-58	-60	-42	-41
Tax Paid ⓘ	-23	-14	-18	-23	-27	-36	-44	-47	-58	-74
Cash Flow From Investing Activity ⓘ	-57	-30	-54	-87	-104	-106	-434	-89	-189	-237
Capex	-48	-31	-55	-81	-45	-104	-93	-150	-237	-269
Net Investments	-9	-1	-2	-8	-62	-7	-344	57	48	20
Others ⓘ	1	2	3	2	3	5	3	4	0	12
Cash Flow From Financing Activityⓘ	-9	-31	-1	14	-10	-22	319	-40	-8	-17
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	400	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-8	-8	-7	-9	-12	-9	-8	-4	-8	-10
Dividend Paid ⓘ	-10	-27	-13	-5	-21	-42	0	-24	-24	-29
Others ⓘ	10	4	19	29	23	30	-73	-12	24	22
Net Cash Flow ⓘ	-2	1	0	3	-1	-1	1	-2	0	2

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	36.34	22.75	22.81	23.28	18.58	22.85	18.74	14.4	15.52	18.74
ROCE (%)	39.37	26.14	25.3	25.96	22.92	24.64	21.62	17.68	19.34	23.28
Asset Turnover Ratio	1.19	1.1	1.08	1.02	0.97	0.91	0.75	0.69	0.73	0.75
PAT to CFO Conversion(x)	1.03	1.32	0.98	1.07	1.71	1.38	0.89	0.86	1.1	1.02
Working Capital Days
Receivable Days	51	64	72	74	73	69	65	70	70	67
Inventory Days	45	43	40	45	44	49	51	54	57	52
Payable Days	119	116	117	127	112	131	108	94	95	84

Poly Medicure Ltd Stock News

Poly Medicure Ltd FAQs

What is the share price of Poly Medicure?

Company share prices are keep on changing according to the market conditions. The closing price of Poly Medicure on 04-Nov-2024 15:31 is ₹2,864.

What is the market cap of Poly Medicure?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Nov-2024 15:31 the market cap of Poly Medicure stood at ₹32,018.9.

What is the P/E ratio of Poly Medicure?

The latest P/E ratio of Poly Medicure as of 04-Nov-2024 15:31 is 109.8.

What is the P/B ratio of Poly Medicure?

The latest P/B ratio of Poly Medicure as of 04-Nov-2024 15:31 is 12.44.

What is the 52-week high and low of Poly Medicure?

The 52-week high of Poly Medicure is ₹3,350 and the 52-week low is ₹1,361.

What is the TTM revenue of Poly Medicure?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Poly Medicure is ₹1,452 ( Cr.) .

About Poly Medicure Ltd

Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

POLYMED manufactures its products using state of the art technology in ultra modern facilities covering over 300,000 square feet of manufacturing floor space with about 50,000 square feet of clean rooms of class 100,000 to class 1,000. A tool room with modern facilities & CNC machines supports the manufacturing processes. A high degree of automation and an effective process control helps in delivering consistent product quality.

To keep pace with the ever changing requirements of the market, POLYMED has a fully staffed and highly equipped R & D section to design and develop new and innovative products. Using the latest CAD/CAM technology, the new product development is fast and improvements, based on market response and customer feedback, are made with ease. Assuring world class products at affordable prices is the hall mark of POLYMED

Product range of the company:

The company manufactures different products related to :